LLOYD PINA: Open Payments
NPI 1669990412 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 59 payments from 11 companies in 2025. Trend: 2023 $1,165 · 2024 $1,194 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $718 |
| Amgen Inc. | 19 | $194 |
| AstraZeneca Pharmaceuticals LP | 2 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $107 |
| Lilly USA, LLC | 4 | $101 |
| PFIZER INC. | 4 | $98 |
| Cipher Pharmaceuticals US LLC | 1 | $80 |
| Exact Sciences Corporation | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Globus Medical, Inc. | 1 | $19 |
Products named: Kerendia, JARDIANCE, OTEZLA, XIFAXAN, TRUMENBA, AIRSUPRA, BREZTRI, Natroba.
Industry payments across TX — which companies pay providers there.
